Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zileuton in moderate to severe facial acne vulgaris
NCT00098358Phase 2Unknown
- Sponsor
- Critical Therapeutics, Inc.
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zileuton extended release in acne vulgaris, sponsored by Critical Therapeutics, Inc.. Status: unknown.
02
Drugs
zileuton extended release
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00098358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098358.